Model-based evaluation of the pharmacokinetic differences between adults and children for lopinavir and ritonavir in combination with rifampicin
about
Tuberculosis: opportunities and challenges for the 90-90-90 targets in HIV-infected childrenGetting to 90-90-90 in paediatric HIV: What is needed?Tackling virological failure in HIV-infected children living in Africa.Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis.Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations.Pharmacokinetics and drug-drug interactions of lopinavir/ritonavir administered with first and second-line antituberculosis drugs in HIV-infected children treated for multidrug-resistant tuberculosis.
P2860
Model-based evaluation of the pharmacokinetic differences between adults and children for lopinavir and ritonavir in combination with rifampicin
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Model-based evaluation of the ...... in combination with rifampicin
@en
Model-based evaluation of the ...... n combination with rifampicin.
@nl
type
label
Model-based evaluation of the ...... in combination with rifampicin
@en
Model-based evaluation of the ...... n combination with rifampicin.
@nl
prefLabel
Model-based evaluation of the ...... in combination with rifampicin
@en
Model-based evaluation of the ...... n combination with rifampicin.
@nl
P2093
P2860
P50
P356
P1476
Model-based evaluation of the ...... in combination with rifampicin
@en
P2093
Chao Zhang
Mats O Karlsson
P2860
P304
P356
10.1111/BCP.12101
P407
P577
2013-11-01T00:00:00Z